SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-16-041746
Filing Date
2016-11-10
Accepted
2016-11-10 15:53:38
Documents
50
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q inbp20161101_10q.htm 10-Q 504542
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 14106
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 14042
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 6572
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 6134
  Complete submission text file 0001437749-16-041746.txt   3012514

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT inbp-20160930.xml EX-101.INS 504215
7 XBRL TAXONOMY EXTENSION SCHEMA inbp-20160930.xsd EX-101.SCH 38980
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inbp-20160930_cal.xml EX-101.CAL 35852
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inbp-20160930_def.xml EX-101.DEF 265183
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE inbp-20160930_lab.xml EX-101.LAB 219665
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inbp-20160930_pre.xml EX-101.PRE 278336
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31668 | Film No.: 161987891
SIC: 2834 Pharmaceutical Preparations